€
0.72
Oct 15
Business Description
CSPC Pharmaceutical Group Ltd
ISIN : HK1093012172
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 27.75 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.05 | |||||
Interest Coverage | 196.02 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.34 | |||||
Beneish M-Score | -1.91 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.4 | |||||
3-Year EBITDA Growth Rate | 3.2 | |||||
3-Year EPS without NRI Growth Rate | 3.6 | |||||
3-Year FCF Growth Rate | -25.6 | |||||
3-Year Book Growth Rate | 11.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 6.06 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.48 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.05 | |||||
9-Day RSI | 49.63 | |||||
14-Day RSI | 53.85 | |||||
6-1 Month Momentum % | -24.61 | |||||
12-1 Month Momentum % | -23.87 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.54 | |||||
Quick Ratio | 2.22 | |||||
Cash Ratio | 1.03 | |||||
Days Inventory | 123.61 | |||||
Days Sales Outstanding | 68.07 | |||||
Days Payable | 113.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.29 | |||||
Dividend Payout Ratio | 0.52 | |||||
3-Year Dividend Growth Rate | 12.8 | |||||
Forward Dividend Yield % | 4.74 | |||||
5-Year Yield-on-Cost % | 14.29 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 4.15 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.38 | |||||
Operating Margin % | 22.99 | |||||
Net Margin % | 18.72 | |||||
FCF Margin % | 7.24 | |||||
ROE % | 17.71 | |||||
ROA % | 12.83 | |||||
ROIC % | 23.61 | |||||
ROC (Joel Greenblatt) % | 61.83 | |||||
ROCE % | 20.82 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 12.92 | |||||
Forward PE Ratio | 11.5 | |||||
PE Ratio without NRI | 12.92 | |||||
Shiller PE Ratio | 11.75 | |||||
Price-to-Owner-Earnings | 25.33 | |||||
PEG Ratio | 0.92 | |||||
PS Ratio | 2.42 | |||||
PB Ratio | 2.19 | |||||
Price-to-Tangible-Book | 2.13 | |||||
Price-to-Free-Cash-Flow | 33.13 | |||||
Price-to-Operating-Cash-Flow | 18.16 | |||||
EV-to-EBIT | 8.07 | |||||
EV-to-Forward-EBIT | 8.47 | |||||
EV-to-EBITDA | 8.07 | |||||
EV-to-Forward-EBITDA | 7.83 | |||||
EV-to-Revenue | 1.92 | |||||
EV-to-Forward-Revenue | 1.78 | |||||
EV-to-FCF | 27.84 | |||||
Price-to-Projected-FCF | 0.94 | |||||
Price-to-DCF (Earnings Based) | 0.36 | |||||
Price-to-DCF (FCF Based) | 0.93 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.82 | |||||
Price-to-Graham-Number | 1.05 | |||||
Price-to-Net-Current-Asset-Value | 5.17 | |||||
Earnings Yield (Greenblatt) % | 12.4 | |||||
FCF Yield % | 3.23 | |||||
Forward Rate of Return (Yacktman) % | 18.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
CSPC Pharmaceutical Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 4,056.18 | ||
EPS (TTM) (€) | 0.064 | ||
Beta | 0.14 | ||
Volatility % | 46.98 | ||
14-Day RSI | 53.85 | ||
14-Day ATR (€) | 0.039341 | ||
20-Day SMA (€) | 0.69311 | ||
12-1 Month Momentum % | -23.87 | ||
52-Week Range (€) | 0.5172 - 0.9716 | ||
Shares Outstanding (Mil) | 11,595.88 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CSPC Pharmaceutical Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CSPC Pharmaceutical Group Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
CSPC Pharmaceutical Group Ltd Frequently Asked Questions
What is CSPC Pharmaceutical Group Ltd(STU:CVG)'s stock price today?
When is next earnings date of CSPC Pharmaceutical Group Ltd(STU:CVG)?
Does CSPC Pharmaceutical Group Ltd(STU:CVG) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |